PGxAI is an AI-powered pharmacogenetics platform that redefines precision medicine using proprietary algorithms and real-world data. Partnered with InterSystems, the largest patient data holder globally, and leveraging advanced tools like VectorSearch and GenAI, PGxAI accesses extensive real-world data to solve drug selection, dosage personalization, and identification of clinically relevant drug-drug interactions.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 330 E Charleston Rd, Palo Alto,california 94306,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- pharmacogeneics, biotechnology, pharmacy, longevity, aging, psychodelics, drugs, metabolism, genes, DNA.
- HQ
- Palo Alto, California
Pgxai Questions
Pgxai's website is https://www.crunchbase.com/organization/pgxai
Pgxai's LinkedIn profile is https://www.linkedin.com/company/pgxai
Pgxai has
13 employees.
View email and phone details for 13
employees at Pgxai.
Pgxai's industry is
Biotechnology Research
Pgxai's top competitors are
Avenue Biosciences,
Aikium Inc.,
Nucleate Bay Area,
Tcg Labs Soleil,
Level Zero Health,
Signios Biosciences,
Curve Biosciences,
Futurehouse,
Trace Neuroscience,
Arda Therapeutics.
Pgxai's categories are Biotechnology Research
Pgxai's founding year is 2023
